Gerresheimer AG’s revenue grew 6.7% year-over-year during its third quarter — with adjusted earnings up 2% — as medical plastic systems continued to be a revenue growth driver, especially due to the company’s U.S. inhaler project.
Revenues for the quarter ended Aug. 31 were 353.7 million euros (equivalent to $399.7 million), up from 331.5 million euros ($374.6 million) during the same period a year ago, the Duesseldorf, Germany–based company announced today. Adjusted net income was 32 million euros ($36.3 million), or 1.02 euro per share ($1.15 per share), up from 31.3 million euros ($35.4 million), or 1 euro per share ($1.13 per share), a year before.
DeviceTalks Minnesota's leadership track is designed to provide attendees with insights on topics such as:
Use code SAVE15 to save 15%!